| Ankur Mogla, MD | |
|
410 Birchwood Ave Ste 200, Bellingham, WA 98225-1783 | |
| (360) 734-9233 | |
| Not Available |
| Full Name | Ankur Mogla |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Nephrology |
| Location | 410 Birchwood Ave Ste 200, Bellingham, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023502325 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | MD61402368 (Washington) | Primary |
| Entity Name | Mt. Baker Nephrology Associates Inc Ps |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104029339 PECOS PAC ID: 7113814971 Enrollment ID: O20040304000515 |
News Archive
A new study published in the March 2020 issue of the journal Experimental Results reports that based on data from over 6,500 subjects, the commonly used AQ10 test is not relevant in diagnosing autism. That means a re-examination of the approach used at present to pick up this condition in the population at large is needed. It also means there is a question mark on the validity of research based on this test.
Atonomics announces today that it has entered into an agreement with Omron Healthcare, which will enable Atonomics to advance the development of the AtolyzerConsumer device for advanced diagnostic testing of lifestyle diseases in a consumer pharmacy setting. As part of the transaction Omron Healthcare is taking a minority equity stake in Atonomics.
Palliative care services are available at most U.S. cancer centers, although the scope of services offered and the degree of integration between palliative care and oncology care varies widely among centers, according to a study in the March 17 issue of JAMA, a theme issue on cancer.
A new study published in the Journal of the National Cancer Institute indicates that the customary pembrolizumab dose for treatment of metastatic non-small cell lung cancer may be higher than is needed for effective treatment.
Observational studies measuring homocysteine concentrations in healthy individuals have found that, on average, those with high levels of homocysteine in their blood are more likely to have a stroke. But other factors that increase homocysteine concentration and stroke risk— such as smoking and socioeconomic class—may be responsible for the relationship observed in these studies, confounding the result.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ankur Mogla, MD 410 Birchwood Ave Ste 200, Bellingham, WA 98225-1783 Ph: (360) 734-9233 | Ankur Mogla, MD 410 Birchwood Ave Ste 200, Bellingham, WA 98225-1783 Ph: (360) 734-9233 |
News Archive
A new study published in the March 2020 issue of the journal Experimental Results reports that based on data from over 6,500 subjects, the commonly used AQ10 test is not relevant in diagnosing autism. That means a re-examination of the approach used at present to pick up this condition in the population at large is needed. It also means there is a question mark on the validity of research based on this test.
Atonomics announces today that it has entered into an agreement with Omron Healthcare, which will enable Atonomics to advance the development of the AtolyzerConsumer device for advanced diagnostic testing of lifestyle diseases in a consumer pharmacy setting. As part of the transaction Omron Healthcare is taking a minority equity stake in Atonomics.
Palliative care services are available at most U.S. cancer centers, although the scope of services offered and the degree of integration between palliative care and oncology care varies widely among centers, according to a study in the March 17 issue of JAMA, a theme issue on cancer.
A new study published in the Journal of the National Cancer Institute indicates that the customary pembrolizumab dose for treatment of metastatic non-small cell lung cancer may be higher than is needed for effective treatment.
Observational studies measuring homocysteine concentrations in healthy individuals have found that, on average, those with high levels of homocysteine in their blood are more likely to have a stroke. But other factors that increase homocysteine concentration and stroke risk— such as smoking and socioeconomic class—may be responsible for the relationship observed in these studies, confounding the result.
› Verified 8 days ago
Katherine Morgan, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2592 Kwina Rd, Bellingham, WA 98226 Phone: 360-384-0464 | |
Hannah Sheinin, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2979 Squalicum Pkwy, Suite 301, Bellingham, WA 98225 Phone: 360-734-1420 Fax: 360-756-6666 | |
Dr. Sumner Todd Mcallister, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 722 N State St, Bellingham, WA 98225 Phone: 360-752-2865 | |
Amir Gharaei, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3015 Squalicum Pkwy, Suite 140, Bellingham, WA 98225 Phone: 360-788-6112 | |
Scott Michael Letellier, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3301 Squalicum Pkwy, Bellingham, WA 98225 Phone: 360-788-8222 Fax: 360-788-7759 | |
Dr. Sukhjit Singh Shergill, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4545 Cordata Pkwy, Suite 2b, Bellingham, WA 98226 Phone: 360-738-2200 Fax: 360-752-5683 |